StockWatch
·
Pharmaceuticals
Management Change4 Aug 2026, 02:23 pm

Morepen Labs CMD Sushil Suri Re-appointed for 3 Years

AI Summary

Morepen Laboratories Ltd announced the re-appointment of Mr. Sushil Suri as Chairman & Managing Director for a further period of three years, effective from October 20, 2026, to October 19, 2029. This decision is subject to shareholder approval at the upcoming 41st Annual General Meeting (AGM). The Board also approved un-audited standalone and consolidated financial results for the quarter ended June 30, 2026, and set a record date for final dividend determination. Additionally, the company is seeking member approval for extending the timeline to hive off its Medical Devices Business into a subsidiary.

Key Highlights

  • Sushil Suri re-appointed as CMD for three years from Oct 2026.
  • Re-appointment subject to shareholder approval at the 41st AGM.
  • Board approved Q1 FY27 un-audited financial results.
  • Plan to hive off Medical Devices Business into a subsidiary.
  • Record date set for final dividend for FY26.